NLRP3 and Insulin resistance: Moreover, activation of the NLRP3 inflammasome contributes to insulin resistance through the release of IL-1β, which, beyond its systemic effects, acts locally in adipose tissue by suppressing IRS-1 expression via both ERK-dependent and -independent mechanisms and by reducing GLUT4 expression and translocation [86].